Molecular Complexity of MDS and AML with Aberrations of Chromosome 7
Hemato · 18.09.2025 · 6 (3) · 34
DOI: 10.3390/hemato6030034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hemato, online erschienen am 18.09.2025. Verfasst von Ugo Testa und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Complete or partial deletions of chromosome 7 (-7/del7q) represent the most frequent chromosomal abnormalities observed in myeloid neoplasms (MNs) and are associated with a poor prognosis. -7/del7q is observed in 10–15% of adult patients with myelodysplasia (MDS) or with acute myeloid leukemia (AML). The occurrence of -7/del7q is particularly frequent in pediatric MDS, often associated with germline mutations of GATA2 or SAMD9/SAMD9L genes. The disease biology of -7/del7q and the genes driving leukemic development have not been completely elucidated, but the haploinsufficiency of tumor suppressor genes located in chromosome 7 deleted regions seems to play a relevant role. The response to standard treatments based either on chemotherapy or hypomethylating agents plus Venetoclax is limited. No approved targeted therapies exist for patients with -7/del7q; however, some recent studies have discovered some vulnerabilities of these myeloid neoplasms than can be efficiently targeted.
Zitieren
APA
Testa, U., Pelosi, E., & Castelli, G. (2025). Molecular Complexity of MDS and AML with Aberrations of Chromosome 7. Hemato, 6(3), 34. https://doi.org/10.3390/hemato6030034
Vancouver
Testa U, Pelosi E, Castelli G. Molecular Complexity of MDS and AML with Aberrations of Chromosome 7. Hemato. 2025;6(3):34. doi:10.3390/hemato6030034
BibTeX
@article{Testa2025,
author = {Testa, Ugo and Pelosi, Elvira and Castelli, Germana},
title = {Molecular Complexity of MDS and AML with Aberrations of Chromosome 7},
journal = {Hemato},
year = {2025},
volume = {6},
number = {3},
pages = {34},
doi = {10.3390/hemato6030034}
}
EUVIMED